Updated:
415 Ventures
415 Ventures is a private investment entity based in Lanham, Maryland, founded in 2007. It focuses on sectors such as healthcare, biotechnology, artificial...
415 Ventures
415 Ventures is a private investment entity based in Lanham, Maryland, founded in 2007. It focuses on sectors such as healthcare, biotechnology, artificial intelligence, and robotics. The firm has made 2 investments, including a Seed VC investment in Prellis Biologics on July 10, 2017.
General information
Firm type
Venture Capital
Year founded
2007
Location
Region
North America
Country
United States
City
Lanham
Corporate office
Lanham, MD, United States
Principals
Frank J. Fischer
Managing Partner
Medhi S. Shariati
Managing Partner
Frederik Groenewegen
Managing Partner
Tomasz Kolodziejak
Founder
Michael R.
Principal, NY Real Estate
Ben Baum
Principal, NY Real Estate
Sector focus
Frequently asked questions
Does 415 Ventures participate in fund commitments or only direct deals?
All known investment activity — venture studio mentoring and direct real estate ownership — is direct. The firm has not disclosed any commitments to external funds. However, Kolodziejak's role at Techstars and Plug and Play is as a mentor, not an LP, so fund commitments through those programs cannot be confirmed.
What is 415 Ventures's known posture on co-investments alongside external GPs?
No co-investments with external GPs have been disclosed. The firm's venture-studio approach and direct real estate ownership — a Bronx mixed-use building, two residential assets on the West Coast and in Oklahoma, and a Munich medtech portfolio — are held internally. Co-investment terms, if any exist, are negotiated deal by deal.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: